What is CorMedix's cash ratio?

CorMedix (CRMD) reported cash ratio of 1.4× in Q1 2026.

How has CorMedix's cash ratio changed year-over-year?

CorMedix's cash ratio decreased by 28.0% year-over-year, from 1.9× to 1.4×.

What is the long-term trend for CorMedix's cash ratio?

Over 5 years (2020 to 2025), CorMedix's cash ratio has grown at a -39.3% compound annual growth rate (CAGR), from 10.1× to 0.8×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

CorMedix CRMD Cash ratio

Cash ratio at other companies

PfizerPFE

0.1×0.0×

Merck & Co.MRK

0.2×-0.1×

Merit Medical SystemsMMSI

2.3×+0.2×

ITG

Integer HoldingsITGR

0×-0.1×

IAR

Integra LifeSciencesIART

0.7×+0.4×

Emergent BiosolutionsEBS

1.1×-0.3×

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

cash and equivalents/total current liabilities=1.4×

Based on the most recent quarter.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's cash ratio?: CorMedix (CRMD) reported cash ratio of 1.4× in Q1 2026.
How has CorMedix's cash ratio changed year-over-year?: CorMedix's cash ratio decreased by 28.0% year-over-year, from 1.9× to 1.4×.
What is the long-term trend for CorMedix's cash ratio?: Over 5 years (2020 to 2025), CorMedix's cash ratio has grown at a -39.3% compound annual growth rate (CAGR), from 10.1× to 0.8×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.